Nanoparticles for the Targeted Delivery of Therapeutic Agents to the Brain for the Treatment of Dementias.
Lead Research Organisation:
University of Bristol
Department Name: Clinical Science at North Bristol
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Organisations
People |
ORCID iD |
| Seth Love (Principal Investigator) |
Publications
Barua NU
(2012)
Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model.
in Fluids and barriers of the CNS
Barua NU
(2012)
Convection-enhanced delivery of neprilysin: a novel amyloid-ß-degrading therapeutic strategy.
in Journal of Alzheimer's disease : JAD
Du Z
(2014)
The role of the helper lipid on the DNA transfection efficiency of lipopolyplex formulations.
in Scientific reports
Miners JS
(2011)
Aß-degrading enzymes: potential for treatment of Alzheimer disease.
in Journal of neuropathology and experimental neurology
| Description | See previous reports (this grant finished in 2013). |
| Exploitation Route | See previous reports (this grant finished in 2013). |
| Sectors | Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |